Study to Assess Adverse Events and Change in Disease Activity of Oral Cariprazine Capsules in Adult Participants With Schizophrenia

NCT05368558 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

34

Enrollment

INDUSTRY

Sponsor class

Stopped Strategic considerations

Conditions

Schizophrenia

Interventions

DRUG: Cariprazine
DRUG: Placebo

Sponsor

AbbVie